Abstract:Upregulation of epidermal growth factor receptor (EGFR) and subsequent increases in extracellular-regulated kinase (ERK) and Akt signaling are implicated in prostate cancer progression. Impaired endocytic downregulation of EGFR also contributes to oncogenic phenotypes such as metastasis. Thus, understanding the roles of divergent signaling pathways in the regulation of EGFR trafficking and EGFR-driven invasive migration may enable the development of more effective therapies. In this study, we use the human prostate cancer cell lines, DU145 and PC3, to investigate the effects of both the ERK and Akt pathways on epidermal growth factor (EGF)-mediated EGFR signaling, trafficking and cell motility. We show that DU145 and PC3 cells overexpress EGFR and migrate in a ligand (EGF)-dependent manner. Next, we show that pharmacological inhibition of ERK (but not Akt) signaling enhances EGF-induced EGFR activation, ubiquitination and downregulation, and may lead to enhanced receptor turnover. These findings negatively correlate with ERK-mediated threonine phosphorylation of EGFR, implicating it as a possible mechanism. Further, we uncover that EGF promotes disassembly of cell–cell junctions, downregulation of E-cadherin and upregulation of the transcriptional repressor, Snail, typical characteristics of epithelial–mesenchymal transition (EMT). These effects are dependent on activation of Akt, as inhibition of Akt signaling abolishes EGF/EGFR-driven cell migration and EMT. Knockdown of endogenous Snail also prevents EGFR-mediated downregulation of E-cadherin, EMT and cell migration. Surprisingly, inhibition of the ERK pathway augments EGFR-dependent motility, occurring concomitantly with elevation of EGF-induced Akt activity. Collectively, our results suggest that EGF-triggered ERK activation has profound feedback on EGFR signaling and trafficking by EGFR threonine phosphorylation, and Akt has a pivotal role in EGFR-mediated cell migration by activating EMT. More important, our results also suggest that therapeutic targeting of ERK signaling may have undesirable outcomes (for example, augmenting EGFR-driven motility).

Adaptor Protein APPL1 Interacts with EGFR to Orchestrate EGF-stimulated Signaling

O-GlcNAcylation regulates epidermal growth factor receptor intracellular trafficking and signaling

APPL1 Promotes the Migration of Gastric Cancer Cells by Regulating Akt2 Phosphorylation.

APPL1 potentiates insulin sensitivity by facilitating the binding of IRS1/2 to the insulin receptor.

APPLs: More Than Just Adiponectin Receptor Binding Proteins

The Interaction of Akt with APPL1 Is Required for Insulin-stimulated Glut4 Translocation

Appl1-Mediating Leptin Signaling Contributes To Proliferation And Migration Of Cancer Cells

Adaptor Protein APPL2 Affects Adult Antidepressant Behaviors and Hippocampal Neurogenesis Via Regulating the Sensitivity of Glucocorticoid Receptor.

Deficiency of APPL1 in mice impairs glucose-stimulated insulin secretion through inhibition of pancreatic beta cell mitochondrial function

Adaptor protein APPL1 couples synaptic NMDA receptor with neuronal prosurvival phosphatidylinositol 3-kinase/Akt pathway.

Phosphoglycerate kinase 1 acts as a cargo adaptor to promote EGFR transport to the lysosome

Fyn and TOM1L1 Are Recruited to Clathrin-Coated Pits and Regulate Akt Signaling.

YAP Modulates TGF-β1-induced Simultaneous Apoptosis and EMT Through Upregulation of the EGF Receptor

Amyloid Precursor Like Protein-1 Promotes Jnk-Mediated Cell Migration In Drosophila

APLN Promotes the Proliferation, Migration, and Glycolysis of Cervical Cancer Through the PI3K/AKT/mTOR Pathway

Adaptor Protein APPL1 Links Neuronal Activity to Chromatin Remodeling in Cultured Hippocampal Neurons.

Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells

Critical role for the catalytic activity of phospholipase C-γ1 in epidermal growth factor-induced cell migration

[Regulation on EGFR Function Via Its Interacting Proteins and Its Potential Application].

Abstract A12: YAP‐dependent induction of amphiregulin identifies a non‐cell‐autonomous component of the Hippo pathway

APPL1-mediated Activation of STAT3 Contributes to Inhibitory Effect of Adiponectin on Hepatic Gluconeogenesis